Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-05 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-05 |